These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15467236)

  • 1. Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2004 Oct; 52(10):1204-9. PubMed ID: 15467236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto Si; Yanagisawa I
    Bioorg Med Chem; 2003 Aug; 11(17):3735-45. PubMed ID: 12901918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.
    Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ
    J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YM-53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents.
    Ugawa T; Kakuta H; Moritani H; Inagaki O; Shikama H
    Br J Pharmacol; 2003 May; 139(1):140-6. PubMed ID: 12746232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles.
    Brown GR; Hollinshead DM; Stokes ES; Clarke DS; Eakin MA; Foubister AJ; Glossop SC; Griffiths D; Johnson MC; McTaggart F; Mirrlees DJ; Smith GJ; Wood R
    J Med Chem; 1999 Apr; 42(7):1306-11. PubMed ID: 10197973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel propylamine derivatives as orally active squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Yanagisawa I
    Bioorg Med Chem; 2004 Nov; 12(22):5899-908. PubMed ID: 15498666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.
    Ciosek CP; Magnin DR; Harrity TW; Logan JV; Dickson JK; Gordon EM; Hamilton KA; Jolibois KG; Kunselman LK; Lawrence RM
    J Biol Chem; 1993 Nov; 268(33):24832-7. PubMed ID: 8227045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species.
    Ugawa T; Kakuta H; Moritani H; Matsuda K; Ishihara T; Yamaguchi M; Naganuma S; Iizumi Y; Shikama H
    Br J Pharmacol; 2000 Sep; 131(1):63-70. PubMed ID: 10960070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
    Ugawa T; Kakuta H; Moritani H; Shikama H
    Br J Pharmacol; 2002 Mar; 135(6):1572-8. PubMed ID: 11906972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of squalene synthase of rat liver by novel 3' substituted quinuclidines.
    McTaggart F; Brown GR; Davidson RG; Freeman S; Holdgate GA; Mallion KB; Mirrlees DJ; Smith GJ; Ward WH
    Biochem Pharmacol; 1996 Jun; 51(11):1477-87. PubMed ID: 8630089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
    Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
    J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.
    Ichikawa M; Yokomizo A; Itoh M; Haginoya N; Sugita K; Usui H; Terayama K; Kanda A
    Bioorg Med Chem; 2011 Sep; 19(17):5207-24. PubMed ID: 21802309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of YM-53601, a novel squalene synthase inhibitor, on the clearance rate of plasma LDL and VLDL in hamsters.
    Ugawa T; Kakuta H; Moritani H; Inagaki O
    Br J Pharmacol; 2002 Oct; 137(4):561-9. PubMed ID: 12359639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
    Chrysselis MC; Rekka EA; Kourounakis PN
    J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.
    Miki T; Kori M; Mabuchi H; Tozawa R; Nishimoto T; Sugiyama Y; Teshima K; Yukimasa H
    J Med Chem; 2002 Sep; 45(20):4571-80. PubMed ID: 12238936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine.
    Ward WH; Holdgate GA; Freeman S; McTaggart F; Girdwood PA; Davidson RG; Mallion KB; Brown GR; Eakin MA
    Biochem Pharmacol; 1996 Jun; 51(11):1489-501. PubMed ID: 8630090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenoxypropylamines: a new series of squalene synthase inhibitors.
    Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB
    J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541
    [No Abstract]   [Full Text] [Related]  

  • 20. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
    Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
    Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.